Focus of Pharmacologic Agents Used in Rapid Sequence Intubation (RSI)

Author(s): Doanh T Ly, RN, DNP, CNS, CCRN, SCRN

Contact Hours 1.00

CERP A 1.00

Pharmacology Hours 0.70

Expires Dec 31, 2028

Topics: Pharmacology

Population: Adult

Role: APRN, Staff

Fees
Member: Free
NonMember: $10.00

Added to Collection

Activity Summary

Before you Begin

1. Reflect on the following question: What new knowledge or perspective do you hope to gain from this activity?

2. Review: Implicit Bias and its Impact on Patient Outcomes (License requirement for California)

Description

Rapid sequence intubation (RSI) is a critical procedure used to quickly secure an airway in patients who are unstable and at risk for aspiration. It involves the administration of intravenous sedatives and neuromuscular blocking agents to facilitate intubation. This presentation explores commonly used agents such as etomidate, ketamine, propofol, succinylcholine and rocuronium and examine their pharmacologic profiles and hemodynamic effects following RSI. Recommendations based on the 2023 Society of Critical Care Medicine Clinical Practice Guidelines for RSI are also explored. Pharmacology content = 70%

Objectives

  • Describe the indications and critical techniques for rapid sequence intubation (RSI) to rapidly secure an airway.
  • Discuss pharmacologic profiles, mechanisms of action, hemodynamic effects of sedatives and neuromuscular blocking agents used in RSI.
  • Apply evidence-based recommendations from the 2023 SCCM Clinical Practice Guideline for patient safety and outcomes during peri-RSI period.

Continuing Education Disclosure Statement

Criteria for Awarding Contact Hours

Learners must complete the entire activity and the associated evaluation AND read Implicit Bias impacts patient outcomes. No partial credit will be awarded.

Accreditation

American Association of Critical-Care Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Provider approved by the California Board of Registered Nursing, Provider number CEP 1036, for {contactHours} contact hours.

Disclosures

The Nurse Planner has determined that no individuals with the ability to control content of this activity have relevant relationships with ineligible companies.

Activities with pharmacotherapeutic credit are to assist the APRN in fulfilling their education requirements for licensure and certification renewals.

Refund Policy

Continuing Education Activities are nonrefundable.